Erica Carey, a presenter for the KeepWell partnership powered by Vida Health, outlined a preventive cardiometabolic program the county’s benefits managers say could be added as a bolt‑on to the existing health plan.
Carey said the program centers on human‑led care — health coaches supported by registered dietitians, diabetes educators, therapists and physician oversight — and integrates claims and eligibility feeds from Blue Cross Blue Shield to target outreach. Participants can use an app with chat, lessons, device integration (scales and activity trackers) and 24/7 messaging with assigned coaches, she said.
Horton Group staff member Beth explained why the county is considering the program now: many high‑cost prescriptions and specialty drugs (including GLP‑1 injectables used for diabetes) are major drivers of pharmacy spend, and Vida’s emphasis on behavior change aims to reduce progression to chronic disease. Carey cited Vida outcomes from their data: an average 7–10% weight loss for participating members and that roughly 96–97% of people identified as prediabetic in their cohorts do not progress to diabetes after participation.
On cost, the program would be billed per engaged member. Horton Group said the PEPM (per‑engaged‑member per month) charge for participants would be about $55; Carey said devices and mailings are included in that engagement fee and that the county would not be charged for individuals who enroll but then stop engaging. Horton Group shared a conservative first‑year projection of about 14–17 enrollees for LaSalle County that would translate to an estimated program investment near $3,000 and projected savings on medical costs in the first year on the order of $9,000–$10,000 (Horton Group presented that as roughly a 4:1 ROI in their projection).
Committee members asked questions about exercise and local vendor relationships. Carey said coaches tailor physical‑activity plans to each participant’s capability, and her team can follow up on local food‑service vendors or programs if asked. Horton Group and Carey also discussed how the program would be positioned if the county later decides to cover GLP‑1s or other anti‑obesity medications: Vida can operate as a foundational behavioral program and, if the county adds medication coverage in the future, Vida would provide clinical obesity management and care coordination to align medication prescribing with appropriate clinical pathways.
Horton Group told the committee it would return with a formal recommendation and asked the committee to consider the Vida program at the county’s August 27 meeting; the committee did not vote on adoption during this session.
Next procedural step: Horton Group intends to include the Vida recommendation in the August renewal materials for committee action; the county board vote would follow the committee’s recommendation in September if approved.